Cargando…
Oligometastatic disease from differentiated thyroid cancer: best treatment schemes
Patients with slowly progressive and/or symptomatic oligometastatic radioactive iodine refractory (RAIR) differentiated thyroid carcinomas (DTCs) are candidates to receive locoregional treatment to delay the start of systemic therapy with multikinase inhibitors. Information provided by the recent li...
Autores principales: | Colombo, Elena, Ottini, Arianna, Licitra, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794151/ https://www.ncbi.nlm.nih.gov/pubmed/36475458 http://dx.doi.org/10.1097/CCO.0000000000000921 |
Ejemplares similares
-
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
por: Colombo, Carla, et al.
Publicado: (2021) -
Risk Factors for Nonsynchronous Second Primary Malignancy and Related Death in Patients with Differentiated Thyroid Carcinoma
por: Lang, Brian Hung-Hin, et al.
Publicado: (2011) -
Evaluating the Prognostic Factors Associated with Cancer-specific Survival of Differentiated Thyroid Carcinoma Presenting with Distant Metastasis
por: Lang, Brian Hung-Hin, et al.
Publicado: (2012) -
Surgical Complications and Referral Patterns in 567 Patients with Differentiated Thyroid Cancer in the Northern Region of the Netherlands: A Population-Based Study Towards Clinical Management Implementation
por: van Dijk, Deborah, et al.
Publicado: (2020) -
Metastasis to the Thyroid Gland: A Critical Review
por: Nixon, Iain J., et al.
Publicado: (2016)